AngioDynamics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AngioDynamics generated cash of -$28,158,000, which is less than the previous year. Cash used in financing activities reached the amount of -$64,248,000 last year. Net change in cash is therefore $31,436,000.
Cash Flow
| 2015 | 26.24M | -13.29M | -10.46M |
|---|---|---|---|
| 2016 | 45.21M | -7.56M | -23.66M |
| 2017 | 55.74M | -2.55M | -37.98M |
| 2018 | 41.28M | -3.65M | -11.55M |
| 2019 | 37.44M | 82.55M | 33.93M |
| 2020 | -14.55M | -63.34M | -95.24M |
| 2021 | 24.09M | -13.71M | -16.98M |
| 2022 | -7.19M | -19.30M | 7.68M |
| 2023 | 78K | -9.74M | 25.42M |
| 2024 | -28.15M | 123.71M | -64.24M |
ANGO Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 44.62M | 28.82M | 48.16M | 54.43M | 227.64M | 74.09M | 47.54M | 32.33M | 18.39M | 16.10M |
Operating activities | ||||||||||
Net income | -184.34M | -52.44M | -26.54M | -31.54M | -165.78M | 61.34M | 16.33M | 7.00M | -44.45M | -3.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 27.71M | 30.87M | 29.34M | 25.91M | 23.80M | 25.88M | 23.16M | 24.81M | 28.37M | 30.49M |
Stock-based compensation expense | 10.52M | 11.15M | 10.69M | 8.62M | 7.59M | 9.24M | 0 | 6.18M | 3.24M | 5.99M |
| Deferred income tax benefit | 10.52M | 11.15M | 10.69M | 8.62M | 7.59M | 9.24M | 0 | 6.18M | 3.24M | 5.99M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 7.89M | -1.29M | -17.15M | -4.16M | 11.91M | -3.17M | 5.04M | 8.47M | 3.13M | 2.09M |
Inventories | -9.41M | -8.19M | -2.79M | 11.53M | -18.84M | -1.42M | 5.74M | 687K | 11.97M | -6.15M |
Accounts payable | 27.53M | 2.13M | 3.91M | 4.87M | -15.16M | 5.21M | -7.09M | 17.21M | -3.39M | -5.87M |
Cash generated by operating activities | -28.15M | 78K | -7.19M | 24.09M | -14.55M | 37.44M | 41.28M | 55.74M | 45.21M | 26.24M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2M | 0 |
Investments In Property Plant And Equipment | -2.51M | -4.35M | -4.29M | -13.71M | -7.58M | -3.11M | -3.65M | -3.00M | -5.59M | -13.29M |
Acquisitions Net | 0 | 0 | -3.6M | 0 | -55.76M | -84.92M | 0 | 0 | -3.29M | 0 |
Cash generated by investing activities | 123.71M | -9.74M | -19.30M | -13.71M | -63.34M | 82.55M | -3.65M | -2.55M | -7.56M | -13.29M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 1.17M | 2.68M | 3.01M | 0 | 2.03M | 2.94M | 0 | 2.43M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -759K | 0 | 0 | -13.55M | 0 | 0 |
Repayments of term debt | -50M | 25M | 5M | -20M | -132.5M | 40M | -5M | -25.27M | -16.25M | -5M |
Cash used in financing activities | -64.24M | 25.42M | 7.68M | -16.98M | -95.24M | 33.93M | -11.55M | -37.98M | -23.66M | -10.46M |
Net Change In Cash | 31.43M | 15.79M | -19.33M | -6.27M | -173.20M | 153.54M | 26.55M | 15.21M | 13.94M | 2.28M |
Cash at end of period | 76.05M | 44.62M | 28.82M | 48.16M | 54.43M | 227.64M | 74.09M | 47.54M | 32.33M | 18.39M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |